PAVMED was established in 2004 empowering to introduce the Amplatzer occluder device into the Korean Market. It is the first device of its kind approved by the FDA, a dramatically less-invasive alternative to cardiac surgery for patients with congenital heart defects by AGA Medical Corporation, a global leader for treating congenital heart defects. Besides distributing SenTec Digital PCO2 Monitor, Medivance Arctic Sun, Wolfetory Abviser and MAD 300, 700, etc., PAVMED became the exclusive distributors of Smiths Medical, ASD. PAVMED strives to meet the needs of our customers through quickly acquiring information on new medical devices. In fostering skilled workforce through continuous education, PAVMED endeavors to gain customer trust by providing quality services. PAVMED will listen attentively to customer requirements with an open mind. Thank you.